Regulatory News

Statement in relation to recent media speculation

RNS Number : 0298M
Darktrace PLC
19 May 2022

19 May, 2022

Darktrace plc



 Darktrace statement in relation to recent media speculation


Darktrace notes the recent share price movement and also media speculation about the company in relation to the civil proceedings in connection with the sale of Autonomy. Neither Darktrace nor any of its acting executives was a party to the civil proceedings. Neither Darktrace nor its acting executives are the target of any investigation. We see no link between Darktrace and the civil action against Dr Mike Lynch by Hewlett Packard or its subsidiaries. There has been no change to the prospects or trading of the business since our last update.






Luk Janssens - Head of Investor Relations, Darktrace 
[email protected]



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.